BACKGROUND: Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated risk factors per gender enable future assessment of the impact of vaccination on HPV dynamics.METHODS: Before the start of national HPV vaccination for girls, data were collected cross-sectionally in nationwide Dutch sexually transmitted infections (STI) clinics among heterosexual males (n = 430) and females (n = 1136) aged 16 to 24 years. Self-collected vaginal or penile swabs were analyzed by a sensitive polymerase chain reaction (SPF10) and genotyped with line probe assay. Logistic regression was applied to estimate determinants of HPV prevalent infections.RESULTS: HPV prevalence was 54% among males and 72% among females. High-risk (HR) HPV ...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
Background: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
Background: We assessed age- and type-specific HPV prevalence, incidence and persistence and their a...
BACKGROUND: Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated ri...
BACKGROUND: Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated ri...
Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated risk factors p...
Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated risk factors p...
To determine differences in the seroprevalence of high-risk human papillomavirus (hrHPV) types betwe...
To determine differences in the seroprevalence of high-risk human papillomavirus (hrHPV) types betwe...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
BACKGROUND: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
BACKGROUND: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
Background: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
Background: We assessed age- and type-specific HPV prevalence, incidence and persistence and their a...
BACKGROUND: Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated ri...
BACKGROUND: Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated ri...
Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated risk factors p...
Baseline genotype-specific human papillomavirus (HPV) prevalence rates and associated risk factors p...
To determine differences in the seroprevalence of high-risk human papillomavirus (hrHPV) types betwe...
To determine differences in the seroprevalence of high-risk human papillomavirus (hrHPV) types betwe...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
BACKGROUND: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
BACKGROUND: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in t...
Background: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection d...
Background: We assessed age- and type-specific HPV prevalence, incidence and persistence and their a...